Commission workshop attracts EU candidates
This article was originally published in Clinica
As Clinica went to press , the European Commission was expecting some 70 participants at its EU accession countries workshop (Prague, June 2-4) on best practices in medical device regulations. Participants were expected from the EU 25, as well as from Switzerland, Turkey, Bulgaria and Romania, to hear about market surveillance and classification issues. Clinica FILED 1 June 2005 COPYRIGHT T&F Informa UK Ltd 2005
You may also be interested in...
After announcing positive topline Phase II results for its Alzheimer’s candidate late last year, Korea's GemVax releases additional data showing significant improvement in secondary outcomes, further raising expectations for the novel peptide drug.
The US FDA’s decision to ask on device adverse event reports whether the device involved had been serviced by a third party could help the agency as well as device makers, says Ricki Chase, compliance practice director at Lachman Consultant Services.
The FDA has almost 30 decision dates coming up before New Year’s Eve, including nearly a dozen novel agents.